Statements (56)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:computer
|
gptkbp:can_be |
gptkb:item
gptkb:public_square Powder Granules Pellets Sustained-release Enteric-coated Powdered drugs |
gptkbp:composed_of |
Gelatin
Vegetable cellulose |
gptkbp:developed_by |
Pharmaceutical companies
|
https://www.w3.org/2000/01/rdf-schema#label |
Capsule System
|
gptkbp:improves |
Bioavailability
|
gptkbp:is_associated_with |
Better patient adherence
Faster absorption Less gastrointestinal irritation |
gptkbp:is_available_in |
Various sizes
Different colors Different shapes |
gptkbp:is_considered |
Convenient dosage form
Flexible formulation option Innovative delivery method |
gptkbp:is_designed_for |
Drug delivery
|
gptkbp:is_part_of |
Pharmaceutical industry
Drug formulation process Pharmaceutical formulation |
gptkbp:is_subject_to |
Quality control
Regulatory oversight Manufacturing standards |
gptkbp:is_tested_for |
gptkb:Dissolution
Safety Stability Efficacy |
gptkbp:is_used_for |
gptkb:item
Nutraceuticals Herbal supplements |
gptkbp:is_used_in |
gptkb:Research_Institute
Clinical trials Development |
gptkbp:is_used_to |
Improve compliance
Facilitate swallowing Mask taste |
gptkbp:is_utilized_in |
Personalized medicine
Combination therapies Targeted therapies |
gptkbp:manufacturer |
Capsule manufacturers
|
gptkbp:provides |
Controlled release
|
gptkbp:regulates |
gptkb:FDA
gptkb:EMA |
gptkbp:suitable_for |
Healthcare professionals
Tablets Patients |
gptkbp:uses |
Capsules
|
gptkbp:bfsParent |
gptkb:Mario_Party_5
|
gptkbp:bfsLayer |
4
|